icd10coded.com
  • ICD-10 CM
    • ICD-10 CM Diagnosis Codes
    • Convert ICD-9 to ICD-10
    • Index of Diseases and Injuries
    • Index of External Cause of Injuries
    • Table of Neoplasms
    • Table of Drugs & Chemicals
    • POA Reporting Guidelines
    • POA Codes
    • Diagnosis Related Groups - MS-DRG
  • ICD-10 PCS
    • ICD-10 PCS Procedure Codes
    • ICD-10 PCS Index
    • ICD-10 PCS Definitions
    • Device Aggregation Table
    • Diagnosis Related Groups - MS-DRG
  • Coding Rules
    • Perinatal/Newborn diagnoses
    • Pediatric diagnoses
    • Maternity diagnoses
    • Adult diagnoses
    • Diagnoses for females only
    • Diagnoses for males only
    • Procedures for females only
    • Procedures for males only
    • Unacceptable principal diagnosis
    • Questionable admission codes
    • Manifestation code as principal diagnosis
  • Clinical Concept
    • Allergy
    • Cardiology
    • Endocrinology
    • Family Practice
    • Internal Medicine
    • OB/GYN
    • Orthopedics
    • Pediatrics
    • Physical Therapy
  • Search
  1. Home
  2. ICD-10 CM
  3. F16.99
  4. Feedback

ICD-10 Code F16.99
Hallucinogen use, unspecified with unspecified hallucinogen-induced disorder

“Hallucinogen use, unsp w unsp hallucinogen-induced disorder” for short

F16.99 is a billable ICD-10-CM code used to specify a diagnosis of unspecified hallucinogen use with an unspecified hallucinogen-induced disorder. In a clinical context, this code is assigned when a patient exhibits health issues resulting from the consumption of hallucinogenic substances, but the documentation lacks sufficient detail to categorize the specific pattern of use as abuse or dependence, or fails to pinpoint the exact nature of the induced condition. Hallucinogens encompass a wide variety of mind-altering substances including lysergic acid diethylamide, psilocybin mushrooms, mescaline, phencyclidine, ketamine, and methylenedioxymethamphetamine. Related conditions that may fall under the clinical umbrella of this code include hallucinogen intoxication, hallucinogen persisting perception disorder or flashbacks, substance-induced psychotic disorders featuring hallucinations or delusions, substance-induced anxiety or mood disorders, and acute substance-induced delirium. It is typically utilized in emergency or preliminary diagnostic settings where substance involvement is evident, but comprehensive psychiatric evaluations are still pending.


F16.99 is a valid billable ICD-10 diagnosis code for Hallucinogen use, unspecified with unspecified hallucinogen-induced disorder. It is found in the 2027 version of the ICD-10 CM Index and can be used in all HIPAA-covered transactions from Oct 01, 2026 - Sep 30, 2027.


MS-DRG - Medicare Severity-Diagnosis Related Group
  • MDC 20 Alcohol/Drug Use & Alcohol/Drug Induced Organic Mental Disorders
    Alcohol/Drug Abuse or Dependence, Left AMA
    • DRG 894 - ALCOHOL, DRUG ABUSE OR DEPENDENCE, LEFT AMA
  • MDC 20 Alcohol/Drug Use & Alcohol/Drug Induced Organic Mental Disorders
    Alcohol/Drug Abuse or Dependence
    • DRG 895 - ALCOHOL, DRUG ABUSE OR DEPENDENCE WITH REHABILITATION THERAPY
    • DRG 896 - ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITH MCC
    • DRG 897 - ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MCC

Coding structure:

ICD-10 code F16.99 is based on the following Tabular structure:

Chapter 5: Mental, Behavioral and Neurodevelopmental disorders
  • Section F10-F19: Mental and behavioral disorders due to psychoactive substance use
    • Category F16: Hallucinogen related disorders

↑ Parent code:
F16.9 for Hallucinogen use, unspecified

F16.99__
Category
 
Etiology, Anatomic Site,
Severity, Other Vital Details
Extension

Should you use F16.99 or F1699 (with or without decimal point) when submitting claims?

DO NOT include the decimal point when electronically filing claims as it may be rejected. Some clearinghouses may remove it for you but to avoid having a rejected claim due to an invalid ICD-10 code, do not include the decimal point when submitting claims electronically.

Section F10-F19 — Mental and behavioral disorders due to psychoactive substance use
  1. F16 Hallucinogen related disorders

    Includes:

    • ecstasy
    • PCP
    • phencyclidine
    1. F16.1 Hallucinogen abuse

      1. F16.10 Hallucinogen abuse, uncomplicated

        Inclusion term(s):

        • Other hallucinogen use disorder, mild
        • Phencyclidine use disorder, mild
      2. F16.11 Hallucinogen abuse, in remission

        Inclusion term(s):

        • Other hallucinogen use disorder, mild, in early remission
        • Other hallucinogen use disorder, mild, in sustained remission
        • Phencyclidine use disorder, mild, in early remission
        • Phencyclidine use disorder, mild, in sustained remission
      3. F16.12 Hallucinogen abuse with intoxication

        • F16.120 Hallucinogen abuse with intoxication, uncomplicated
        • F16.121 Hallucinogen abuse with intoxication with delirium
        • F16.122 Hallucinogen abuse with intoxication with perceptual disturbance
        • F16.129 Hallucinogen abuse with intoxication, unspecified
      4. F16.14 Hallucinogen abuse with hallucinogen-induced mood disorder

        Inclusion term(s):

        • Other hallucinogen use disorder, mild, with other hallucinogen induced bipolar or related disorder
        • Other hallucinogen use disorder, mild, with other hallucinogen induced depressive disorder
        • Phencyclidine use disorder, mild, with phencyclidine induced bipolar or related disorder
        • Phencyclidine use disorder, mild, with phencyclidine induced depressive disorder
      5. F16.15 Hallucinogen abuse with hallucinogen-induced psychotic disorder

        • F16.150 Hallucinogen abuse with hallucinogen-induced psychotic disorder with delusions
        • F16.151 Hallucinogen abuse with hallucinogen-induced psychotic disorder with hallucinations
        • F16.159 Hallucinogen abuse with hallucinogen-induced psychotic disorder, unspecified
      6. F16.18 Hallucinogen abuse with other hallucinogen-induced disorder

        • F16.180 Hallucinogen abuse with hallucinogen-induced anxiety disorder
        • F16.183 Hallucinogen abuse with hallucinogen persisting perception disorder (flashbacks)
        • F16.188 Hallucinogen abuse with other hallucinogen-induced disorder
      7. F16.19 Hallucinogen abuse with unspecified hallucinogen-induced disorder

    2. F16.2 Hallucinogen dependence

      1. F16.20 Hallucinogen dependence, uncomplicated

        Inclusion term(s):

        • Other hallucinogen use disorder, moderate
        • Other hallucinogen use disorder, severe
        • Phencyclidine use disorder, moderate
        • Phencyclidine use disorder, severe
      2. F16.21 Hallucinogen dependence, in remission

        Inclusion term(s):

        • Other hallucinogen use disorder, moderate, in early remission
        • Other hallucinogen use disorder, moderate, in sustained remission
        • Other hallucinogen use disorder, severe, in early remission
        • Other hallucinogen use disorder, severe, in sustained remission
        • Phencyclidine use disorder, moderate, in early remission
        • Phencyclidine use disorder, moderate, in sustained remission
        • Phencyclidine use disorder, severe, in early remission
        • Phencyclidine use disorder, severe, in sustained remission
      3. F16.22 Hallucinogen dependence with intoxication

        • F16.220 Hallucinogen dependence with intoxication, uncomplicated
        • F16.221 Hallucinogen dependence with intoxication with delirium
        • F16.229 Hallucinogen dependence with intoxication, unspecified
      4. F16.24 Hallucinogen dependence with hallucinogen-induced mood disorder

        Inclusion term(s):

        • Other hallucinogen use disorder, moderate, with other hallucinogen induced bipolar or related disorder
        • Other hallucinogen use disorder, moderate, with other hallucinogen induced depressive disorder
        • Other hallucinogen use disorder, severe, with other hallucinogen-induced bipolar or related disorder
        • Other hallucinogen use disorder, severe, with other hallucinogen-induced depressive disorder
        • Phencyclidine use disorder, moderate, with phencyclidine induced bipolar or related disorder
        • Phencyclidine use disorder, moderate, with phencyclidine induced depressive disorder
        • Phencyclidine use disorder, severe, with phencyclidine induced bipolar or related disorder
        • Phencyclidine use disorder, severe, with phencyclidine-induced depressive disorder
      5. F16.25 Hallucinogen dependence with hallucinogen-induced psychotic disorder

        • F16.250 Hallucinogen dependence with hallucinogen-induced psychotic disorder with delusions
        • F16.251 Hallucinogen dependence with hallucinogen-induced psychotic disorder with hallucinations
        • F16.259 Hallucinogen dependence with hallucinogen-induced psychotic disorder, unspecified
      6. F16.28 Hallucinogen dependence with other hallucinogen-induced disorder

        • F16.280 Hallucinogen dependence with hallucinogen-induced anxiety disorder
        • F16.283 Hallucinogen dependence with hallucinogen persisting perception disorder (flashbacks)
        • F16.288 Hallucinogen dependence with other hallucinogen-induced disorder
      7. F16.29 Hallucinogen dependence with unspecified hallucinogen-induced disorder

    3. F16.9 Hallucinogen use, unspecified

      1. F16.90 Hallucinogen use, unspecified, uncomplicated

      2. F16.91 Hallucinogen use, unspecified, in remission

      3. F16.92 Hallucinogen use, unspecified with intoxication

        • F16.920 Hallucinogen use, unspecified with intoxication, uncomplicated
        • F16.921 Hallucinogen use, unspecified with intoxication with delirium

          Inclusion term(s):

          • Other hallucinogen intoxication delirium
        • F16.929 Hallucinogen use, unspecified with intoxication, unspecified
      4. F16.94 Hallucinogen use, unspecified with hallucinogen-induced mood disorder

        Inclusion term(s):

        • Other hallucinogen induced bipolar or related disorder, without use disorder
        • Other hallucinogen induced depressive disorder, without use disorder
        • Phencyclidine induced bipolar or related disorder, without use disorder
        • Phencyclidine induced depressive disorder, without use disorder
      5. F16.95 Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder

        • F16.950 Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder with delusions
        • F16.951 Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder with hallucinations
        • F16.959 Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder, unspecified

          Inclusion term(s):

          • Other hallucinogen induced psychotic disorder, without use disorder
          • Phencyclidine induced psychotic disorder, without use disorder
      6. F16.98 Hallucinogen use, unspecified with other specified hallucinogen-induced disorder

        • F16.980 Hallucinogen use, unspecified with hallucinogen-induced anxiety disorder

          Inclusion term(s):

          • Other hallucinogen-induced anxiety disorder, without use disorder
          • Phencyclidine induced anxiety disorder, without use disorder
        • F16.983 Hallucinogen use, unspecified with hallucinogen persisting perception disorder (flashbacks)
        • F16.988 Hallucinogen use, unspecified with other hallucinogen-induced disorder
      7. F16.99 Hallucinogen use, unspecified with unspecified hallucinogen-induced disorder

Abbreviations used here:

NEC Not elsewhere classifiable
This abbreviation in the Tabular List represents “other specified”. When a specific code is not available for a condition, the Tabular List includes an NEC entry under a code to identify the code as the “other specified” code.

NOS Not otherwise specified
This abbreviation is the equivalent of unspecified.

This note further define, or give examples of, the content of the code or category.

List of terms is included under some codes. These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of “other specified” codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.

Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10 CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.

A type 1 Excludes note is a pure excludes. It means 'NOT CODED HERE!' An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.

A type 2 Excludes note represents 'Not included here'. An Excludes2 note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When an Excludes2 note appears under a code it is acceptable to use both the code and the excluded code together.

A “code also” note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction. The sequencing depends on the circumstances of the encounter.

Certain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions, the ICD-10 CM has a coding convention that requires the underlying condition be sequenced first, if applicable, followed by the manifestation. Wherever such a combination exists, there is a “use additional code” note at the etiology code, and a “code first” note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation.

Feedback

Finding the right ICD-10 code is not always easy. Submitting the wrong code can cause delays in processing claims and payments. Please let us know if there is anything we can do better to help make your job easier. We strive to be the best ICD-10 site possible.

Share this page

Was the information found on this page useful? Share this page with a friend or colleague. They may also find it useful. We can send an email to someone you designate with this information as well.

  • ICD-10 CM
  • ICD-10 PCS
  • FAQs
  • Sitemap
  • →
  • Terms of Use
  • Privacy Policy
  • Contact Us
Follow @icd10coded

ICD-10 data provided by CMS (Centers for Medicare & Medicaid Services). All content is provided “AS IS”. The latest version of ICD-10 is updated each year on October 1.

1.261103a — Privacy Settings